Bridgewater Associates’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-83,806
Closed -$2.96M 1008
2026
Q1
$2.96M Sell
83,806
-260,646
-76% -$8.09M 0.01% 557
2025
Q4
$9.64M Buy
+344,452
New +$10.3M 0.04% 366
2024
Q2
Sell
-7,400
Closed -$200K 880
2024
Q1
$200K Sell
7,400
-33,584
-82% -$954K ﹤0.01% 674
2023
Q4
$1.14M Buy
40,984
+8,083
+25% +$210K 0.01% 619
2023
Q3
$922K Sell
32,901
-1,367
-4% -$40.1K 0.01% 622
2023
Q2
$1.07M Sell
34,268
-223
-0.6% -$6.75K 0.01% 564
2023
Q1
$972K Sell
34,491
-6,046
-15% -$165K 0.01% 566
2022
Q4
$1.06M Buy
40,537
+12,311
+44% +$295K 0.01% 636
2022
Q3
$630K Sell
28,226
-1,427
-5% -$37.1K ﹤0.01% 755
2022
Q2
$883K Buy
29,653
+2,041
+7% +$58.6K ﹤0.01% 806
2022
Q1
$726K Buy
27,612
+8,280
+43% +$205K ﹤0.01% 840
2021
Q4
$450K Buy
19,332
+2,449
+15% +$64.4K ﹤0.01% 654
2021
Q3
$521K Buy
16,883
+589
+4% +$16.6K ﹤0.01% 590
2021
Q2
$400K Buy
+16,294
New +$362K ﹤0.01% 667

Other funds holding ALKS

Bridgewater Associates's ALKS Position: Q2 2026 in Review

Bridgewater Associates sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 83,806 shares — an estimated $2.96M sold.

Bridgewater Associates first reported a position in ALKS in Q2 2021 and held it in 14 quarters. The position peaked at $9.64M in Q4 2025. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Bridgewater Associates reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
  • Bridgewater Associates sold 83,806 Alkermes shares in Q2 2026, an estimated $2.96M.
  • Bridgewater Associates first reported a position in Alkermes in Q2 2021 and held it in 14 quarters.
  • Bridgewater Associates's Alkermes position peaked at $9.64M in Q4 2025.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.